4//SEC Filing
MEMORY PHARMACEUTICALS CORP 4
Accession 0001209191-09-000901
CIK 0001062216operating
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:02 PM ET
Size
7.7 KB
Accession
0001209191-09-000901
Insider Transaction Report
Form 4
KRIEBEL ROBERT I
Director
Transactions
- Disposition from Tender
Common Stock
2009-01-01$0.61/sh−5,000$3,050→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2009-01-05$0.20/sh−10,000$2,000→ 0 totalExercise: $0.41Exp: 2018-06-12→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]This option, which provided for vesting on the first anniversary of the grant date, was canceled in connection with the Issuer's merger with 900 North Point Acquisition Corporation on January 5, 2009. In exchange, the Reporting Person received a cash payment of $2,000, which represents the difference between the exercise price of the option and the offer price of $0.61 per share multiplied by the number of shares underlying the option.
Documents
Issuer
MEMORY PHARMACEUTICALS CORP
CIK 0001062216
Entity typeoperating
Related Parties
1- filerCIK 0001062216
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:02 PM ET
- Size
- 7.7 KB